# BioXcel Therapeutics, Inc.: Form 8-K, filed Sep 15, 2025

- Company: [BioXcel Therapeutics, Inc.](/companies/btaiq.md) (CIK 1720893)
- Form: 8-K
- Filed: 2025-09-15
- Accepted by EDGAR: Sep 15, 2025, 08:30 ET
- Period: 2025-09-15
- Accession: 0001104659-25-089773
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1720893/000110465925089773/tm2526080d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1720893/000110465925089773/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1720893/000110465925089773/tm2526080d1_8k.htm

Filed Sep 15, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-089773. Last ingested by Listed: Oct 30, 2026, 17:24 ET. No prices; not investment advice.